Order results by:
| Issue | Title | |
| Vol 16, No 4 (2024) | Agomelatine: pharmacological profile, possible application, advantages | Abstract similar documents |
| V. E. Medvedev, O. V. Kotova, A. V. Palin, O. V. Mikheeva, E. S. Akarachkova | ||
| "... Agomelatine is an antidepressant with a unique pharmacological action that is both a melatonin ..." | ||
| Vol 3, No 2 (2011) | Role of melatonin in the treatment of depression | Abstract similar documents |
| O. V. Kotova | ||
| "... a wide range of drugs that are able to affect melatonin metabolism, amongst which there is agomelatine ..." | ||
| Vol 10, No 4 (2018) | Approaches to therapy for depressions in neurology: prospects for the use of agomelatine | Abstract similar documents |
| D. V. Romanov, B. A. Volel, D. S. Petelin | ||
| "... This review provides information on prospects for using the antidepressant agomelatine ..." | ||
| Vol 15, No 4 (2023) | Experience with agomelatine therapy for non-psychotic depression with a single and recurrent course | Abstract similar documents |
| L. A. Ivanova, A. V. Kovaleva, N. O. Sitnikova | ||
| "... Therapy of depression is a current problem in psychiatry. Agomelatine is not inferior to other ..." | ||
| Vol 13, No 6 (2021) | Treatment of mixed anxiety and depressive disorder: results from a observational study of the efficacy and tolerability of agomelatine | Abstract similar documents |
| D. S. Petelin, I. V. Niinoya, O. V. Sorokina, D. V. Troshina, O. N. Voskresenskaya, B. A. Volel | ||
| "... Objective: to study the efficacy, safety and tolerability of agomelatine in mixed anxiety ..." | ||
| Vol 14, No 1 (2022) | Impact of different classes of antidepressants on sleep and wakefulness regulation in depression | Abstract similar documents |
| G. M. Usov, D. Yu. Kolomytsev, L. M. Lomiashvili | ||
| "... are of particular value in clinical practice. Agomelatine (valdoxan) rapidly improves sleep in depressed patients ..." | ||
| Vol 14, No 2 (2022) | Treatment of mental disorders of generative cycle in women | Abstract similar documents |
| V. E. Medvedev | ||
| "... The clinical and etiological diversity of depressive, anxiety, dysmorphic and psychotic disorders ..." | ||
| Vol 16, No 6 (2024) | Antidepressant and anxiolytic efficacy and tolerability of agomelatine in the treatment of depression after COVID-19 in daily clinical practice (non-interventional study TELESPHOR) | Abstract similar documents |
| V. E. Medvedev, A. N. Bogolepova, D. P. Morozov, B. B. Kvasnikov | ||
| "... Depression and anxiety are among the most common disorders observed in patients after COVID-19 ..." | ||
| Vol 12, No 4 (2020) | Depressions with eating disorders: clinical manifestations and therapy | Abstract similar documents |
| V. E. Medvedev, V. I. Frolova, E. V. Gushanskaya, Yu. S. Fofanova, S. E. Martynov, N. L. Zuikova, A. M. Burno, S. V. Nekrasova, I. V. Salyntsev | ||
| "... with the antidepressant agomelatine (25–50 mg/day at night) for depressions with two ED variants: hyperphagic (n=32 ..." | ||
| Vol 11, No 2 (2019) | Differentiated approach and indications for optimization of agomelatine therapy for endogenous depression | Abstract similar documents |
| L. I. Abramova, G. P. Panteleeva, I. Yu. Nikiforova, T. E. Novozhenova | ||
| "... Objective: to develop and justify differentiated indications for the use of agomelatine (valdoxan ..." | ||
| Vol 11, No 1 (2019) | Antidepressant therapy in patients with cardiovascular diseases | Abstract similar documents |
| V. E. Medvedev, E. A. Korovyakova, V. I. Frolova, E. V. Gushanskaya | ||
| "... the high efficiency and good tolerability of agomelatine, an antidepressant with an innovative mechanism ..." | ||
| Vol 15, No 5 (2023) | Diagnosis and treatment of depression according to the functional recovery paradigm | Abstract similar documents |
| G. M. Usov | ||
| "... that provides a broader therapeutic effect combined with a more favorable tolerability profile. Agomelatine ..." | ||
| Vol 14, No 4 (2022) | Adherence to antidepressant therapy: clinical experience on the example of agomelatine | Abstract similar documents |
| N. N. Petrova | ||
| "... of agomelatine in real clinical settings. The results of a prospective observational multicenter cohort study ..." | ||
| Vol 13, No 2 (2021) | Possibilities of using laboratory biomarkers for the objective diagnosis of depressive disorders | Abstract similar documents |
| V. K. Shamrey, E. S. Kurasov, Ya. S. Zobin, N. V. Tsygan | ||
| "... patients with neurotic depressive disorders (adjustment disorders). The severity of anxiety and depression ..." | ||
| Vol 15, No 2 (2023) | Depression in patients with cerebral microangiopathy | Abstract similar documents |
| A. N. Bogolepova | ||
| "... and safety should be preferred. Agomelatine (Valdoxan) is one of such drugs. ..." | ||
| Vol 9, No 1 (2017) | Correction of sleep disorders in EMERCOM employees: The results of using long-acting melatonin | Abstract similar documents |
| Yu. B. Slizkova, V. A. Bryuzgin | ||
| "... ) and a reduction in anxiety and depression. Conclusion. Long-acting melatonin has a good safety profile and can ..." | ||
| Vol 4, No 3 (2012) | Efficacy of valdoxan in the prevention and treatment of post-stroke depression | Abstract similar documents |
| Dina Rustemovna Khasanova, Yu V Zhitkova, A A Safiullina | ||
| "... The efficacy of valdoxan (agomelatine) used to prevent and treat post-stroke depression ..." | ||
| Vol 10, No 1 (2018) | Cognitive impairment in anxiety disorders | Abstract similar documents |
| B. A. Volel, D. S. Petelin, R. V. Akhapkin, A. A. Malyutina | ||
| "... Anxiety disorders are an important biomedical problem due to the high prevalence and significant ..." | ||
| Vol 2, No 2 (2010) | Possibilities of using Tanakan ® in therapy for generalized anxiety syndrome | Abstract similar documents |
| D. Yu. Veltishchev | ||
| "... The review considers the treatment of anxiety disorders (generalized anxiety and the anxious ..." | ||
| Vol 16, No 5 (2024) | Gidazepam – daytime tranquilizer for the treatment of anxiety | Abstract similar documents |
| Yu. E. Azimova, D. S. Petelin | ||
| Vol 1, No 1 (2009) | MEDICAL INFORMATION IN THE STRUCTURE OF COGNITIVE THERAPY FOR PANIC DISORDER | Abstract similar documents |
| A. M. Burno | ||
| "... on the explanation of the nature of physical and psychopathological symptoms of anxiety. ..." | ||
| Vol 13, No 2 (2021) | Depression, anxiety and motivation in arterial hypertension | Abstract similar documents |
| S. K. Mezhmidinova, V. V. Zakharov, N. V. Vakhnina | ||
| "... of cerebrovascular diseases. Objective: to assess the relationship between anxiety, depression and apathy ..." | ||
| Vol 14, No 4 (2022) | Anxiety-depressive spectrum disorders in cervical dystonia | Abstract similar documents |
| V. A. Tolmacheva, P. G. Yuzbashyan, D. S. Petelin, B. A. Volel, N. I. Salouhina, M. R. Nodel, D. V. Romanov | ||
| "... A decrease in the quality of life (QoL) in cervical dystonia (CD) is often due to anxiety ..." | ||
| Vol 5, No 2 (2013) | Generalized anxiety disorder: Differential diagnosis and treatment | Abstract similar documents |
| Tatyana Gratsiyevna Voznesenskaya | ||
| "... Generalized anxiety disorder (GAD) is poorly diagnosed and inadequately treated by general ..." | ||
| Vol 14, No 1 (2022) | Comparative evaluation of psychopharmacotherapy of atypical depression in bipolar and recurrent affective disorder, psychogenic depression | Abstract PDF (Eng) similar documents |
| M. S. Verbitskaya, N. A. Tyuvina, Yu. G. Tyulpin, G. L. Krenkel | ||
| "... (RDD – 93.2%; PD – 91.5%) compared to other regimens. Agomelatine was the most frequently used (31 ..." | ||
| Vol 11, No 4 (2019) | Clinical and functional remission assessment in patients with recurrent depression | Abstract similar documents |
| N. N. Petrova | ||
| "... symptoms, that with anxiety symptoms, hypothymic. Results and discussion. The criteria for complete ..." | ||
| Vol 13, No 2 (2021) | Anxiety and depression in COVID-19: treatment options | Abstract similar documents |
| V. E. Medvedev | ||
| "... frequency of depression (up to 53.5%), anxiety (up to 50.9%), and mixed anxiety/depressive disorders were ..." | ||
| Vol 16, No 4 (2024) | Aviandr is a new original drug for treating anxiety | Abstract similar documents |
| V. A. Parfenov | ||
| "... reuptake inhibitors (SNRIs) are effective in anxiety disorders (AD). In a significant proportion ..." | ||
| Vol 16, No 5 (2024) | The Effect of Adding Agomelatine to Escitalopram in the Treatment of Major Depressive Disorder | Abstract PDF (Eng) similar documents |
| H. Azadi, P. Rashidpour, S. M. Yassini Ardekani, M. Nadi Sakhvidi, H. Afshang, R. Bidaki | ||
| "... of depression is agomelatine. Objective of this study was to evaluate the effect of adding agomelatine ..." | ||
| Vol 6, No 3 (2014) | Psychogenic urticaria: The issues of diagnosis and optimization of therapy | Abstract similar documents |
| A. A. Pribytkov, E. A. Orlova | ||
| "... ) were examined. The methods included clinical examination; use of the Goldberg anxiety rating scale ..." | ||
| Vol 6, No 4 (2014) | Somatization of anxiety disorders in the practice of a neurologist: Algorithms and approaches to differentiated treatment | Abstract similar documents |
| E. G. Mendelevich | ||
| "... of somatization disorders within generalized anxiety disorder and panic disorder are of interest. One ..." | ||
| Vol 7, No 3 (2015) | Experience with sustained-release melatonin for the treatment of sleep disorders in depression | Abstract similar documents |
| Svetlana Vladimirovna Prokhorova, T. N. Maksimova | ||
| "... The data available in the literature on the role of melatonin in the regulation of circadian ..." | ||
| Vol 4, No 1 (2012) | Use of Addenbrooke’s cognitive examination-revised to evaluate the patients’ state in general medical practice | Abstract similar documents |
| Nikolai Nikolayevich Ivanets, D M Tsarenko, M A Bobrova, A A Kursakov, E G Starostina, A E Bobrov | ||
| "... at somatic hospitals and city polyclinics. It enrolled 130patients (36 men and 94 women) with anxiety ..." | ||
| Vol 15, No 4 (2023) | Comorbid disorders and therapy of persistent postural perceptual dizziness | Abstract similar documents |
| E. N. Zastenskaya, L. M. Antonenko | ||
| "... , assessments by Hospital Anxiety and Depression Scale (HADS), Beck Depression Inventory (BDI), Beck Anxiety ..." | ||
| Vol 15, No 6 (2023) | Chronic dizziness: modern treatment methods taking into account comorbidity | Abstract similar documents |
| E. N. Zastenskaia, L. M. Antonenko | ||
| "... is often combined with other diseases of the vestibular system and anxiety disorders. In real-life clinical ..." | ||
| Vol 13, No 1 (2021) | Anxiety: phenomenology, epidemiology, and risk factors during the novel coronavirus SARS-CoV-2 (COVID-19) pandemic | Abstract similar documents |
| A. G. Merkin, S. S. Akinfieva, A. V. Martyushev-Poklad, O. P. Beloskurskaya, E. N. Dinov, S. L. Ostrovsky, A. N. Komarov, O. Yu. Zakharova, V. A. Kazhin, I. A. Nikiforov, M. Glover | ||
| "... associated inter alia with adverse effects on mental health. One of the most common mental illness is anxiety ..." | ||
| Vol 8, No 3 (2016) | Changes in EEG indices and serotonin concentrations in depression and anxiety disorders | Abstract similar documents |
| I. V. Kichuk, E. A. Petrova, A. A. Mitrofanov, N. V. Solovyeva, V. B. Vilyanov | ||
| "... with anxiety disorders (AD), and 86 control individuals were examined. EEG spectrum and coherence changes were ..." | ||
| Vol 14, No 6 (2022) | Mental disorders in cervical dystonia – clinical heterogeneity, impact on disease severity and quality of life | Abstract similar documents |
| A. A. Ragimova, D. S. Petelin, T. Y. Avseytseva, M. A. Samushia, A. F. Ivolgin | ||
| "... of life was a high level of anxiety. Conclusion. Some patients with CD have comorbid mental disorders ..." | ||
| Vol 11, No 2S (2019): Спецвыпуск: боль в спине и конечностях | Chronic back pain and mental disorders | Abstract similar documents |
| B. A. Volel, D. S. Petelin, D. O. Rozhkov | ||
| "... in the genesis of chronic pain. This review discusses the issues of back pain comorbid with depressive, anxiety ..." | ||
| Vol 9, No 4 (2017) | Neuropsychological pattern of Parkinson's disease | Abstract similar documents |
| A. A. Tappakhov, T. E. Popova, T. Ya. Nikolaeva, N. A. Schnaider, M. M. Petrova, M. R. Sapronova | ||
| "... Рассматривается проблема нейропсихологических расстройств при болезни Паркинсона (БП) – одном из ..." | ||
| Vol 5, No 2 (2013) | Correction of affective and cognitive disorders in epileptic patients and the value of lamotrigine | Abstract similar documents |
| Vladimir Veniaminovich Kalinin | ||
| Vol 15, No 3 (2023) | Clinical effectiveness and safety of prolonged release form of alimemazine in patients with generalized anxiety disorder | Abstract similar documents |
| Ju. E. Azimova, Yu. P. Sivolap, K. A. Ishchenko | ||
| "... treatment of generalized anxiety disorder (GAD). Objective: to investigate the efficacy and safety ..." | ||
| Vol 16, No 1S (2024): Спецвыпуск: Головная боль | A personalized approach to the treatment of chronic tension-type headache: quality of life of patients | Abstract similar documents |
| K. M. Tlisova, D. S. Petelin, O. N. Voskresenskaya, B. A. Volel | ||
| Vol 5, No 3 (2013) | Role of anxiety and depressive disorders in the genesis of psychosomatic disorders | Abstract similar documents |
| Aleksandr Anatolyevich Shatenshtein | ||
| "... of anxiety and depressive disorders were calculated within each disease group. Results. In psychosomatic ..." | ||
| Vol 4, No 2 (2012) | The efficacy and tolerability of paroxetine (adepress), an antidepressant from a group of selective serotonin reuptake inhibitors, in psychoautonomic syndrome within anxiety-depressive disorders | Abstract similar documents |
| T G Voznesenskaya, N M Fokina | ||
| "... effects of adepress in patients with mild and moderate anxiety-depressive disorders and psychoautonomic ..." | ||
| Vol 15, No 5 (2023) | Comparative analysis of the use of selective serotonin reuptake inhibitors during pregnancy and the postpartum period. Safety of sertraline | Abstract similar documents |
| E. A. Ushkalova, A. V. Ushkalova | ||
| "... Depressive disorders and anxiety are the most common mental disorders in the perinatal period ..." | ||
| Vol 13, No 5 (2021) | Association of polymorphic variants of genes (HTR2A, MTNR1A, MTNR1B, CLOCK, DRD2) and insomnia in alcohol dependence syndrome | Abstract PDF (Eng) similar documents |
| I. S. Efremov, A. R. Asadullin, V. S. Dobrodeeva, N. A. Shnayder, E. A. Akhmetova, D. R. Tukhvatullina, E. M. Krupitsky, R. F. Nasyrova | ||
| "... , particularly insomnia, associated with a number of critical clinical aspects, increased suicide risk, anxiety ..." | ||
| Vol 16, No 5 (2024) | Humoral serotonin and neuropsychological status of patients with dizziness | Abstract similar documents |
| I. I. Borodulina, Yu. V. Karakulova | ||
| "... Dizziness is often accompanied by affective disorders such as anxiety and depression ..." | ||
| Vol 14, No 3 (2022) | The impact of non-motor disorders on the quality of life of patients with cervical muscular dystonia | Abstract similar documents |
| M. R. Nodel, N. I. Salouhina, V. A. Tolmacheva | ||
| "... <0.001 ), moderate strength correlation – with indicators of anxiety (r=0.65; p<0 ..." | ||
| Vol 12, No 6 (2020) | Cognitive and emotional impairment in patients with migraine and signs of leukoencephalopathy during preventive therapy | Abstract similar documents |
| K. A. Pozhidaev, V. A. Parfenov | ||
| "... for Epidemiological Studies Depression Scale (CES-D); the Hospital Anxiety and Depression Scale (HADS ..." | ||
| Vol 16, No 1S (2024): Спецвыпуск: Головная боль | Diagnosis of chronic migraine and comorbid neurological disorders in real-life clinical practice | Abstract similar documents |
| V. A. Golovacheva, A. A. Golovacheva, A. R. Tarshilova, V. V. Osipova | ||
| "... their previous treatment, and a psychometric test was performed to assess symptoms of anxiety and depression ..." | ||
| Vol 14, No 5 (2022) | Emotional disorders and their therapy in chronic low back pain | Abstract similar documents |
| A. I. Isaikin, T. I. Nasonova, A. Kh. Mukhametzyanova | ||
| "... of the quality of life and disability. Anxiety and depressive disorders are significantly more common in patients ..." | ||
| Vol 14, No 5 (2022) | Impact of work and study during pandemic on the mental state of medical professionals | Abstract similar documents |
| V. E. Medvedev, O. A. Dogotar, N. Yu. Lyzlova | ||
| "... of psychopathological disorders such as anxiety (44.5%), depression (23.6%), asthenia (86.4%) and eating behavior ..." | ||
| Vol 12, No 1 (2020) | The efficacy and safety of ethyl methyl hydroxypyridine succinate used as part of sequential therapy in patients with chronic cerebral ischemia | Abstract similar documents |
| V. V. Burdakov, D. V. Krasnykh | ||
| "... Cognitive Assessment (MoCA); the Hamilton Anxiety Rating Scale (HARS); asthenia rating scales ..." | ||
| Vol 9, No 3 (2017) | Clinical and psychopathological features of depressions with panic attacks | Abstract similar documents |
| N. N. Ivanets, K. M. Tartynsky, G. L. Krenkel, S. V. Prokhorova | ||
| "... Diagnostic Scale, and the Sheehan Clinical Anxiety Rating Scale. Results. The clinical and psychopathological ..." | ||
| Vol 15, No 3 (2023) | Efficacy and safety of a daytime anxiolytic containing technologically processed antibodies to the S100 protein. Overview of clinical studies | Abstract PDF (Eng) similar documents |
| M. Perez, N. N. Zavadenko, L. A. Skipetrova, I. I. Smirnov, Yu. E. Nesterovskiy | ||
| "... and Tenoten children’s in the treatment of anxiety, neurotic, stress-related and somatoform disorders ..." | ||
| Vol 3, No 4 (2011) | Neurasthenia: history and the present | Abstract similar documents |
| D. Yu. Veltishchev | ||
| "... расстройства. ..." | ||
| Vol 12, No 3 (2020) | Features of the pathogenesis, diagnosis, and treatment of panic attacks in young people | Abstract similar documents |
| M. L. Chukhlovina | ||
| "... to measure the severity of clinical manifestations of PAs; the Covey Anxiety Scale was employed to identify ..." | ||
| Vol 3, No 3 (2011) | ICD-10 and the clinical features of depressions: data of the CIRCADIAN-I program | Abstract similar documents |
| O. V. Serdyuk, A. A. Ovchinnikov, N. A. Kutuzova, M. Yu. Drobizhev, K. Yu. Retyunsky | ||
| "... from this clinical presentation (sensitive, anxiety symptoms, a prolonged course, and no well-defined ..." | ||
| Vol 5, No 4 (2013) | Sleep disorders and their significance in the development of cognitive impairments | Abstract similar documents |
| Irina Sergeyevna Preobrazhenskaya | ||
| "... . Melatonin preparations are noted to be effective in treating insomnia in patients with CI. ..." | ||
| Vol 12, No 6 (2020) | Somatization disorders of affective and neurotic registers during the COVID-19 pandemic (analysis of clinical cases) | Abstract similar documents |
| I. Yu. Dorozhenok | ||
| "... -диагностическую оценку состояния пациентов с расстройствами аффективного и невротического регистров. В таких ..." | ||
| Vol 8, No 2 (2016) | Effectiveness of prolonged-release melatonin in Improving Quality of Sleep in Patients Aged 55 or Over | Abstract similar documents |
| G. V. Kovrov, M. V. Agaltsov, Z. N. Sukmarova | ||
| "... Objective: to evaluate the efficacy of prolonged-release melatonin used in routine practice ..." | ||
| Vol 11, No 2 (2019) | Insomnia in patients with migraine | Abstract similar documents |
| E. M. Evdokimova, G. R. Tabeeva | ||
| "... мигрени (с аурой или без нее) в возрасте 18–65 лет с коморбидным расстройством сна. 1-ю группу составили ..." | ||
| Vol 3, No 4 (2011) | Psychosomatic correlations in atrial fibrillations | Abstract similar documents |
| V. E. Medvedev, K. V. Zverev, A V Epifanov | ||
| "... anxiety and hypochondriacal disorders, which agrees with the data available in the literature. In addition ..." | ||
| Vol 11, No 4 (2019) | Cognitive impairment and mental disorders in patients with focal muscular dystonia | Abstract similar documents |
| V. A. Tolmacheva, D. A. Grishina, D. V. Romanov | ||
| "... performed; the Beck Depression Inventory and the Spielberger State-Trait Anxiety Inventory were used ..." | ||
| No 1S (2016): | Analysis of adult patients with epilepsy in the age continuum | Abstract similar documents |
| V. A. Karlov, O. S. Inozemtseva | ||
| "... the level of anxiety and depression by the Hospital Anxiety and Depression Scale, and assessed the severity ..." | ||
| Vol 15, No 3 (2023) | Mental disorders during the pandemic of a new coronavirus infection: clinical features | Abstract similar documents |
| V. A. Vysokova, N. A. Tyuvina, T. N. Maksimova, S. V. Prokhorova | ||
| "... of the 2nd group had coronavirus infection. Anxiety and depressive disorders prevailed in the 1st group ..." | ||
| Vol 16 (2024): (Suppl. 2) | Multifactorial model of predictors of the development of depressive disorders in multiple sclerosis: a prospective longitudinal study | Abstract PDF (Eng) similar documents |
| K. V. Gubskaia, Yа. V. Malygin, A. Yu. Aleksandrova | ||
| "... (Beta=0.742), reactive anxiety 56±2.64 points on the SpielbergerKhanin scale with an increase of 1 ..." | ||
| Vol 14, No 2 (2022) | Clinical features of atypical depression in bipolar and recurrent affective disorders, psychogenic depression | Abstract PDF (Eng) similar documents |
| N. A. Tyuvina, M. S. Verbitskaya, G. I. Krenkel, E. N. Efremova | ||
| "... characteristic symptoms included: increased appetite, anxiety, asthenia, superficial night sleep, hypochondriacal ..." | ||
| Vol 3, No 2 (2011) | Therapy of depression in patients with focal epilepsy: experience with citalopram use | Abstract similar documents |
| A. V. Lebedeva, E. G. Melikyan, A. B. Gekht | ||
| "... to have varying symptoms of depression. The Hospital Anxiety and Depression Scale (HADS) was used ..." | ||
| 1 - 70 of 479 Items | 1 2 3 4 5 6 7 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
